Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
Harvard Bioscience (NASDAQ: HBIO) has announced it will release its financial results for Q4 2024 before market opening on March 12, 2025. The company will host a conference call at 8:00 AM ET on the same day to discuss the results.
Interested participants who wish to ask questions during the call must pre-register to receive dial-in numbers and a unique PIN. An audio-only webcast option will also be available through the company's investor website. The earnings release and related presentation materials will be accessible through Harvard Bioscience's Investor Relations section.
Harvard Bioscience (NASDAQ: HBIO) ha annunciato che rilascerà i suoi risultati finanziari per il quarto trimestre del 2024 prima dell'apertura del mercato il 12 marzo 2025. L'azienda ospiterà una conferenza telefonica alle 8:00 AM ET dello stesso giorno per discutere i risultati.
I partecipanti interessati che desiderano porre domande durante la chiamata devono registrarsi in anticipo per ricevere i numeri di accesso e un PIN unico. Sarà inoltre disponibile un'opzione di webcast audio-only attraverso il sito web per gli investitori dell'azienda. Il comunicato sugli utili e i materiali di presentazione correlati saranno accessibili attraverso la sezione Relazioni con gli Investitori di Harvard Bioscience.
Harvard Bioscience (NASDAQ: HBIO) ha anunciado que publicará sus resultados financieros para el cuarto trimestre de 2024 antes de la apertura del mercado el 12 de marzo de 2025. La compañía llevará a cabo una conferencia telefónica a las 8:00 AM ET el mismo día para discutir los resultados.
Los participantes interesados que deseen hacer preguntas durante la llamada deben registrarse previamente para recibir los números de acceso y un PIN único. También estará disponible una opción de webcast solo de audio a través del sitio web para inversores de la compañía. El comunicado de ganancias y los materiales de presentación relacionados estarán accesibles a través de la sección de Relaciones con Inversores de Harvard Bioscience.
하버드 바이오사이언스 (NASDAQ: HBIO)는 2024년 4분기 재무 결과를 2025년 3월 12일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시(ET)에 결과를 논의하기 위한 컨퍼런스 콜을 개최합니다.
전화를 통해 질문을 하고자 하는 참가자는 사전 등록을 해야 전화 접속 번호와 고유 PIN을 받을 수 있습니다. 회사의 투자자 웹사이트를 통해 오디오 전용 웹캐스트 옵션도 제공됩니다. 하버드 바이오사이언스의 투자자 관계 섹션을 통해 수익 발표 및 관련 프레젠테이션 자료를 확인할 수 있습니다.
Harvard Bioscience (NASDAQ: HBIO) a annoncé qu'elle publiera ses résultats financiers pour le quatrième trimestre 2024 avant l'ouverture du marché le 12 mars 2025. L'entreprise organisera une conférence téléphonique à 8h00 ET le même jour pour discuter des résultats.
Les participants intéressés souhaitant poser des questions pendant l'appel doivent s'inscrire à l'avance pour recevoir les numéros d'accès et un code PIN unique. Une option de webdiffusion audio uniquement sera également disponible via le site Web des investisseurs de l'entreprise. Le communiqué de résultats et les documents de présentation connexes seront accessibles via la section Relations avec les investisseurs de Harvard Bioscience.
Harvard Bioscience (NASDAQ: HBIO) hat angekündigt, dass die finanziellen Ergebnisse für das 4. Quartal 2024 vor Markteröffnung am 12. März 2025 veröffentlicht werden. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Interessierte Teilnehmer, die während des Anrufs Fragen stellen möchten, müssen sich im Voraus registrieren, um Zugangsdaten und eine eindeutige PIN zu erhalten. Eine Audio-Only-Webcast-Option wird ebenfalls über die Investorenseite des Unternehmens verfügbar sein. Die Ergebnisveröffentlichung und die dazugehörigen Präsentationsmaterialien werden über den Bereich Investor Relations von Harvard Bioscience zugänglich sein.
- None.
- None.
HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2024, before the market opens on March 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120
Investors Contact:
Three Part Advisors
Sandy Martin
HBIO@threepa.com
(214) 616-2207
FAQ
When will Harvard Bioscience (HBIO) release Q4 2024 earnings?
What time is Harvard Bioscience's (HBIO) Q4 2024 earnings call?
How can investors participate in HBIO's Q4 2024 earnings call?
Where can investors find HBIO's Q4 2024 earnings materials?
